UNSPSC 51283717: Cefminox sodium

This classification denotes the sodium form of a cephalosporin antibiotic with the molecular formula C16H21N7O7S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PW08Y13465, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((2s)-2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r,7s)- but more generally known as cefminox, which bears US NIH Compound Identifier 71141.

UNSPSC 51283717 Cefminox sodium is a Commodity code that encompasses specific pharmaceutical products acquired by state and local health agencies. Based on recent state and local procurement activity, the code appears applied inconsistently — the two most recent opportunities tagged to this code concern Doxycycline Hyclate, Ciprofloxacin Hydrochloride, Naloxone, and Safe Drug Deactivation Systems, none of which are cefminox sodium. State and local health departments and county public health agencies do use UNSPSC pharmaceutical commodity codes to procure injectable and oral antibiotics, opioid antagonists, and related pharmaceutical products through piggyback contracts and competitive bidding. These solicitations typically flow through cooperative purchasing consortiums such as MMCAP or directly through county procurement offices, with suppliers required to meet drug-free workplace certification, E-Verify compliance, and standard insurance coverage requirements.

Recent procurement activity appears sparse under this specific code. The Illinois Department of Public Health awarded a piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for pharmaceutical warehouse supply (Bid Number 26-482DPH-PREPD-B-53392), with a total contract value of $2,999,999.11 over three years including renewals. Seminole County, Florida released an IFB on June 30, 2026, for Naloxone and Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building, though the due date listed (July 26, 2023) appears to be a data error and the procurement does not align with the cefminox sodium code's nominal scope. The geographic spread is limited to Florida and Illinois in the recent record, with no visible multi-state pattern. The code shows minimal activity under its stated pharmaceutical classification, suggesting either low demand for cefminox sodium specifically or systematic misclassification in state and local tagging.